|Audit||Compensation and Management Development||Nominating and Corporate Governance|
|Lewis T. "Rusty" Williams, M.D., Ph.D.|
|Franklin M. Berger, CFA|
|Sheila Gujrathi, M.D.|
Dr. Gujrathi has served as a member of our board of directors since December 2015. Dr. Gujrathi served as the Chief Medical Officer of Receptos, Inc., from June 2011 to August 2015 when Receptos was acquired by Celgene Corporation. From 2008 to 2011, Dr. Gujrathi served as Vice President of the Global Clinical Research Group in Immunology at Bristol-Myers Squibb Company. Prior to joining Bristol-Myers Squibb, Dr. Gujrathi worked at Genentech from 2002 to 2008, where she held roles of increasing responsibility in the Immunology, Tissue Growth and Repair clinical development group. From 1999 to 2002, Dr. Gujrathi served as a management consultant at McKinsey & Company in the healthcare practice, where she provided strategic advice on a variety of projects in the healthcare and pharmaceutical industry. Dr. Gujrathi received her B.S. in Biomedical Engineering and M.D. from Northwestern University in their accelerated honors program in Medical Education. She completed her internal medicine internship and residency at Brigham and Women’s Hospital, Harvard Medical School. Dr. Gujrathi received additional training at the University of California, San Francisco and Stanford University in their Allergy and Immunology Fellowship Program.
|Peder K. Jensen, M.D.|
|Mark D. McDade|
|William R. Ringo|